The following is a list of organizations that are participating in the PACT consortium. Participating companies share experiences and insights, help shape variable definitions and data needs, contribute data from actual clinical trials, review and interpret findings, and provide financial support.
To learn more about participating in the PACT Consortium as well as membership levels and benefits, contact Joan Chambers, PACT Director, at joan.chambers@tufts.edu.
- AbbVie
- AstraZeneca
- Bayer
- Biogen
- Bristol Meyers Squibb
- Clinilink
- CSL Behring
- Fortrea
- Genentech
- Gilead
- GSK
- ICON
- IQVIA
- Johnson & Johnson
- Medable
- Medrio
- Medidata
- Moderna
- Novartis
- Novo Nordisk
- Otsuka
- Pfizer
- PPD
- Reagan-Udall Foundation for the Food and Drug Administration
- Regeneron
- Sanofi
- Scimitar Inc
- Takeda
- Tufts Center for the Study of Drug Development
- UCB
- Ultragenyx
- Veristat
Become Involved with the PACT Consortium
Why? The PACT Consortium brings together industry stakeholders to define and measure the actual impact of DCT Solutions in clinical trials and to create actionable strategic solutions for future planning
Contact Us
Interested in joining or learning more about the PACT Consortium?
Please complete the form or send an email to csdd@tufts.edu and we will promptly follow up. Thank you.